Bird Flu Market Size is valued at USD 1.41 Bn in 2023 and is predicted to reach USD 2.17 Bn by the year 2031 at a 5.82% CAGR during the forecast period for 2024-2031.
Bird flu is an infectious type virus that primarily affects birds which can cause severe disease in birds, leading to high mortality rates as well these viruses typically cause milder symptoms and may go unnoticed. The market related to bird flu infection spans pharmaceuticals, vaccines, diagnostics, and poultry industry management, driven by the need to prevent, diagnose, and treat avian influenza outbreaks. Demand for antiviral drugs, human vaccines against potential pandemic strains, and rapid early detection diagnostic tools are key components. The poultry industry, significantly affected by avian influenza, invests in biosecurity measures, surveillance, and vaccination to mitigate economic losses and trade restrictions. Public health preparedness, including government and international organization efforts in surveillance and emergency response, plays a crucial role.
Furthermore, because labour costs are low and raw materials are easily accessible in emerging nations, large firms are concentrating on moving their production facilities there. The market for bird flu treatments is anticipated to develop due to these causes. Additionally, it is anticipated that underdeveloped infrastructure in developing nations would restrict research and development capacities, hence impeding the expansion of the bird flu market. But rising government expenditure on infrastructure development and rising investment by big companies in product development are two things that should open up new doors for businesses in the target market.
The bird flu market can be segmented based on Virus Type, Test Type, Treatment Type, and Animal Type. By Virus Type, the market is segmented into H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, and Others. By Test Type, the market is segmented into PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, and Others. By Treatment Type, the market is segmented into Vaccines, Antiviral Medication, Immunomodulators, and Others; by Animal Type, the market is segmented into Chickens, Ducks, Geese & Swans, Pigeons, Guinea Fowls, Turkeys, and Others.
The pathogenic influenza A virus subtype H5N1 is an emerging bird flu (Avian influenza) virus causing global concern as a potential pandemic threat. H5N1 is a large threat virus in Asia because of infected poultry due to low hygiene conditions and close quarters. It is easy for humans to be safe from bird infection, but human-to-human transmission is more difficult without prolonged contact. Public health officials believe avian flu strains may mutate to become easily transmissible between humans.
Most human cases of bird flu result from either handling dead infected birds or contact with infected fluids, which refers to being spread through contaminated surfaces and droppings. Most seasonal wild birds have only a mild form of the H5N1 strain; some domesticated birds, such as chickens or turkeys, are known to be infected. H5N1 can become much more deadly because the birds are often in close contact.
Along with proper infection control and personal protective equipment (PPE), the chance of infection by bird flu is low. Protecting the eyes, nose, mouth, and hands is crucial for prevention in poultry farms. Felicitous personal protective equipment includes aprons or coveralls, gloves, boots covers, and a head cover. Disposable PPE is recommended. An N-95 respirator with safety goggles is also part of the appropriate PPE. A fueled air purifying respirator (PAPR) with a helmet and face shield is also an option.
North America has taken the lead as the region of choice. Numerous companies producing avian influenza vaccines and diagnostics are in the United States. North America has taken the lead in epidemic planning and prevention strategies thanks to the large chicken markets in the United States and Canada. Tight food safety laws necessitate that commercial poultry farms implement biosecurity measures on a large scale. Major R&D expenditures have been made by top American pharmaceutical corporations to create avian flu vaccinations that are universally effective. This enables North America to combat new strains of avian influenza more effectively before they become widespread worldwide.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 1.41 Bn |
| Revenue Forecast In 2031 | USD 2.17 Bn |
| Growth Rate CAGR | CAGR of 5.82 % from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Virus Type, Test Type, Treatment Type, and Animal Type. |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | Boehringer Ingelheim, Ceva Santé Animale, Zoetis, Merck & Co., Ringpu Biology, Yebio Bioengineering, FATRO, CAVAC, ChengDu Tecbond, QYH Biotech, Elanco, Phibro Animal Health, Vetoquinol, Hipra, Venkys, Anicon Labor GmbH, Medion Farma Jaya, Bioveta, Lohmann Animal Health and Biogenesis Bago, Sanofi, F. Hoffmann-La Roche Ltd., Mallinckrodt, Elanco, GlaxoSmithKline plc, Novartis AG, Bayer AG, Eli Lilly and Company, AstraZeneca, Johnson & Johnson Private Limited, Bimeda, Inc., Phibro Animal Health Corporation, HIPRA, Medion |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
The Bird Flu Market By Virus Type:
The Bird Flu Market By Test Type:
The Bird Flu Market By Treatment and Prevention Type:
The Bird Flu Market By Animal Type:
The Bird Flu Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.